Real-time enrollment status for this glioblastoma clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 10:25 AM UTC
| NCT Number | NCT07225621 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma |
| Phase | PHASE2 |
| Target Enrollment | 103 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Alpheus Medical, Inc. |
| Last Updated on CT.gov | July 17, 2026 (Jul 17, 2026) |
As of August 28, 2026: Clinical trial NCT07225621 is currently recruiting participants. This phase2 study for glioblastoma is actively seeking new participants at 11 locations across the United States. The study is sponsored by Alpheus Medical, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07225621 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07225621 was last updated Jul 17, 2026 (July 17, 2026). HelloStudys verifies this status automatically.